David Baer, MD
Medical Oncologist
Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Pleural Mesothelioma Testicular Mesothelioma
Biological Therapy/Immunotherapy Chemotherapy Gene Therapy Pain Management Photodynamic Therapy Targeted Therapy
Dr. David Baer is specialized in oncology and hematology and practice medicine in Oakland, California. He graduated from University of California San Francisco School of Medicine. At UCSF Medical Center, he did his fellowship, in hematology and oncology, and follow medical studies in residency at KFH San Francisco Medical Center, in internal medicine. Dr. Baer is affiliated with Kaiser Permanente Oakland Medical Center and Dameron Hospital.
University of California San Francisco
Medical School
Kaiser Permanente Medical Center
Internship
Kaiser Permanente Medical Center
Residency
UC San Francisco
Fellowship
American Board of Internal Medicine - Oncology
Kaiser Permanente Oakland Medical Center
Languages: English/Spanish
(510) 752-1000
3772 Howe St
Read MoreAlcohol Intake, Beverage Choice, and Cancer: A Cohort Study in a Large Kaiser Permanente Population.
Klatsky, A. L.,Li, Y.,Tran, H. N.,Baer, D.,Udaltsova, N.,Armstrong, M. A.,Friedman, G. D.; Perm J. 2015 Mar 19.
See more >>Efficacy of abbreviated Stanford V chemotherapy and involved-field radiotherapy in early-stage Hodgkin lymphoma: mature results of the G4 trial.
Advani, R. H.,Hoppe, R. T.,Baer, D.,Mason, J.,Warnke, R.,Allen, J.,Daadi, S.,Rosenberg, S. A.,Horning, S. J.; Ann. Oncol.. 2013 Apr.
See more >>Stage I-IIA Non-bulky Hodgkin's Lymphoma. Is Further Distinction Based on Prognostic Factors Useful? The Stanford Experience.
Advani, R.H., Hoppe, R.T., Maeda, L.S., Baer, D.M., Mason, J., Rosenberg, S.A., Horning, S.J.; Int J Radiat Oncol Biol Phys. 2011 Dec 1.
See more >>